Human Immunology Biosciences
San Diego, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $120M
Overview
A biotech developing novel antibody therapeutics to precisely modulate the immune system for autoimmune and inflammatory diseases.
ImmunologyAutoimmune DiseasesOncology
Technology Platform
A proprietary platform for the discovery and optimization of fully human antibodies targeting novel immunology pathways.
Funding History
1Total raised:$120M
Venture$120M
Opportunities
Potential to address significant unmet needs in autoimmune diseases with a novel, targeted mechanism.
Risk Factors
High risk of preclinical failure and intense competition from established and emerging immunology therapies.
Competitive Landscape
Operates in the highly competitive antibody therapeutics space, competing with large biopharma and numerous biotechs focused on immunology.